SHENZHEN PRO HITU MEDICAL CO., LTD. (formerly known as Shenzhen Pro Huiren Medical Technology Co., Ltd.) was established in 2003 and is dedicated to the development of large therapeutic ultrasound machines. PRO is a national high-tech enterprise that integrates R&D, production, sales and investment services. The company name was officially changed on December 30, 2016.

PRO has successfully developed therapeutic ultrasound machines. One of the machines, which was launched in 2012, is the first large-scale CFDA-certified Class III medical device in China for the non-invasive treatment of gynecological diseases. PRO has also obtained CE certification for this device, making it the world's leading focused ultrasound device for specialized treatments.

PRO has cooperated with the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences, Shanghai Jiao Tong University, Tongji University, Shenzhen University, Hunan Normal University, and Nanjing University. The PRO Research Institute was established in 2005, which constitutes a scientific product development system and a stable and efficient R&D team. PRO focuses on the non-invasive treatment system for gynecological diseases. It has carried out research cooperation with many hospitals and achieved good clinical results. These hospitals include Xiangya Hospital of Central South University, the Second Affiliated Hospital of Zhejiang University, Renji Hospital of Shanghai Jiaotong University School of Medicine, the First Affiliated Hospital of Jinan University, Shuguang Hospital of Shanghai University of Traditional Chinese Medicine, and Peking University People's Hospital.

PRO has dozens of invention and utility model patents and has obtained qualifications such as "National High-tech Enterprise". For several years, PRO has been included in the special support program for major technology industries in Shenzhen and selected as a key future industry support program in Shenzhen. PRO has won many honors such as the Shenzhen Green Medical Technology Innovation Award, the First Prize in the Enterprise Category at the 7th China (Shenzhen) Innovation and Entrepreneurship Competition, and the China Medical Industry Development and Innovation Award.

PRO has always been committed to technological improvement and innovation. We devote major efforts to developing non-invasive treatment devices for chronic pain and tumors such as pancreatic and prostate cancers. We are also working hard to promote the application and development of innovative non-invasive treatment. PRO is determined to become a leader in non-invasive medical technology and bring non-invasive, effective and safe treatments to more medical fields.